The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Twist Bioscience's Revenue for the
three
months ended in Sep. 2024 was $84.7 Mil. Twist Bioscience's average Accounts Receivable for the
three
months ended in Sep. 2024 was $33.4 Mil.
Hence, Twist Bioscience's Receivables Turnover for the
three
months ended in Sep. 2024 was 2.53.
Twist Bioscience Receivables Turnover Historical Data
The historical data trend for Twist Bioscience's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Twist Bioscience's Receivables Turnover
For the Diagnostics & Research subindustry, Twist Bioscience's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Twist Bioscience's Receivables Turnover Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Twist Bioscience's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Twist Bioscience's Receivables Turnover falls into.
Twist Bioscience Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Twist Bioscience's Receivables Turnover for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Twist Bioscience Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Twist Bioscience's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TWST has been successfully added to your 